Purchase Order 75N95021P00619

This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of Qiagen N.V. The $111,768.00 contract does not have a set-aside designation. Qiagen, a provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, is delivering products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. Qiagen holds several...

This is a $3,465 firm fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen Redwood City, Inc., a subsidiary of the multinational biotechnology company Qiagen N.V. The contract is for "INGENUITY VARIANT ANALYSIS" and does not have a set-aside designation, indicating it was competed on an unrestricted basis. Qiagen is a leading provider of molecular...

This is a firm fixed-price BPA call contract awarded by the Office of the Chief Operating Officer, a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The contract is valued at $30,274.36 and has an ultimate completion date of October 27, 2014. Qiagen, LLC is a division of the international biotechnology company Qiagen N.V. and has provided a range of products and services to federal agencies,...

Qiagen, LLC, a subsidiary of Netherlands-based Qiagen N.V., received a delivery order award from the Food and Drug Administration (FDA) on July 24, 2018, for Array Kits valued at $18,126.83 with a firm fixed price contract type. The delivery order was issued without a set-aside designation and is scheduled for ultimate completion on September 30, 2018. Performance will be executed at Qiagen's facility in Valencia, California. This award represents a task order under the FDA's existing indefinite...

Qiagen, LLC was awarded a firm fixed-price Blanket Purchase Agreement (BPA) call for in vitro diagnostic substances, reagents, test kits, and sets valued at $13,132.80, with an ultimate completion date of August 17, 2015. This contract was issued by the Office of the Director at a civilian federal agency without a set-aside designation, reflecting Qiagen's ability to compete in the open federal marketplace. The place of performance is identified as Valencia, California. This award represents a...

This is a firm fixed-price delivery order awarded by the Headquarters Division of the Federal Bureau of Investigation (FBI) to Qiagen, LLC, a division of Qiagen N.V. The contract, valued at $157,000.00, is for the provision of supplies and has a period of performance ending on September 28, 2016. Qiagen is an international provider of sample and assay technologies for biomedical research, public health, law enforcement, and healthcare programs, and has previously served as a prime and...

The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price Delivery Order contract to Qiagen, LLC, a division of Qiagen N.V., for the purchase of molecular biology reagents. The $149,040.91 contract has a completion date of September 26, 2022. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, and has previously provided products and services like DNA/RNA extraction kits,...

This is a $211,853.58 firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, laboratory equipment, and bioinformatics software. The contract is for QCII ONE PRECUR 301-600 TESTING, with a period of performance through May 31, 2027. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has a significant federal contract portfolio supporting biomedical research,...

This is a delivery order awarded by the Department of Health and Human Services Food and Drug Administration to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $27,299.50 firm fixed price contract does not have a set-aside designation. Qiagen has provided a range of goods and services to support federal biomedical research, public health, law enforcement, and healthcare programs, including DNA/RNA extraction kits, next-generation sequencing,...

Qiagen, LLC was awarded a $279,820 firm fixed price definitive contract by an unnamed U.S. government agency to provide biological materials. As the prime contractor, Qiagen will deliver the requested products to the agency's facility in Valencia, California by December 31, 2009. Qiagen is a division of Qiagen N.V., a global leader in sample and assay technologies. No additional details were provided regarding the original solicitation, associated vehicles, or subcontractors. The award does...